Intech Biopharm Corporation (TPEX: 6461)

Intech Biopharm Revenue

Intech Biopharm had revenue of 8.66M TWD in the quarter ending September 30, 2024, with 26.15% growth. This brings the company's revenue in the last twelve months to 34.07M, up 38.38% year-over-year. In the year 2023, Intech Biopharm had annual revenue of 25.85M with 9.30% growth.

• Revenue (ttm): 34.07M
• Revenue Growth: +38.38%
• P/S Ratio: 106.91
• Revenue / Employee: 415.51K
• Employees: 82
• Market Cap: 3.70B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	25.85M	2.20M	9.30%
Dec 31, 2022	23.65M	-15.25M	-39.21%
Dec 31, 2021	38.90M	17.79M	84.30%
Dec 31, 2020	21.11M	4.42M	26.50%
Dec 31, 2019	16.68M	-550.00K	-3.19%